Company
Novelty Nobility
Leadership
SAB
Contact Us
Platform
PREXISE-D
PREXISE-L
Pipeline
People
Culture
Careers
News
Careers
Publications
Blog
OTD Solution
Terms of Use
Private Policy
ddd
Company
Novelty Nobility
Leadership
SAB
Contact Us
Platform
PREXISE-D
PREXISE-L
Pipeline
People
Culture
Careers
News
Careers
Publications
Blog
OTD Solution
Terms of Use
Private Policy
PREXISE-D, Fit-for-Purpose
Antibody Design & Discovery
Learn more
Overcoming Drug Resistance
with Antibody-Drug Conjugate
Learn more
Bringing a Beautiful Moment of
Eye Contact to Everyone
Learn more
NEWS
[메디게이트 뉴스] 노벨티노빌리티, 완전인간항체 발굴 서비스 'PREXISE-D OTD Solution' 국내 ...
[Press release] Novelty Nobility announces IND clearance by U.S. FDA enabling Phase 1 initiation for...
[약업신문] 노벨티노빌리티, 망막질환 항체신약후보 ‘NN2101’ FDA 1상 승인
[약업신문] 노벨티노빌리티 "우수한 항체 기술력에 강력한 ADC 기술을 더하다"...
[더벨]"안질환 영역, 경제적 해자 커…연내 1상 IND 신청"